Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aberle, J. H., Aberle, S. W., Dworzak, M. N., Mandl, C. W., Rebhandl, W., Vollnhofer, G., Kundi, M., and Popow-Kraupp, T. (1999). Reduced Interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am. J. Respir. Crit. Care Med. 160, 1263–1268.
Adkins, B., Leclerc, C., and Marshall-Clarke, S. (2004). Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553–564.
Awomoyi, A. A., Rallabhandi, P., Pollin, T. I., Lorenz, E., Sztein, M. B., Boukhvalova, M. S., Hemming, V. G., Blanco, J. C., and Vogel, S. N. (2007). Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children. J. Immunol. 179, 3171–3177.
Bendelja, K., Gagro, A., Bace, A., Lokar-Kolbas, R., Krsulovic-Hresic, V., Drazenovic, V., Mlinaric-Galinovic, G., and Rabatic, S. (2000). Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin. Exp. Immunol. 121, 332–338.
Bloemers, B., Furth v, A. M., Weijerman, M., Broers, C., Gemke, R. J. B. J., Strengers, J. L. M., Kimpen, J. L. L., and Bont, L. (2007). Increased incidence of respiratory syncytial virus lower respiratory hospitalisation in children with Down syndrome. Pediatrics. 121(4), e1076–1081.
Bont, L., Aalderen, v. W. M. C., and Kimpen, J. L. L. (2000). Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr. Respir. Rev. 1, 221–227.
Bont, L., Heijnen, C. J., Kavelaars, A., van Aalderen, W. M., Brus, F., Draaisma, J. M., Pekelharing-Berghuis, M., Diemen-Steenvoorde, R. A., and Kimpen, J. L. (2001). Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J. Infect. Dis. 184, 355–358.
Bont, L., Kavelaars, A., Heijnen, C. J., van Vught, A. J., and Kimpen, J. L. (2000b). Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J. Infect. Dis. 181, 1772–1775.
Bont, L. and Kimpen, J. L. (2002). Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive Care Med. 28, 616–621.
Cannon, M. J., Openshaw, P. J. M., and Askonas, B. A. (1988). Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168, 1163–1168.
Chang, J. and Braciale, T. J. (2002). Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat. Med. 8, 54–60.
Choi, E. H., Lee, H. J., Yoo, T., and Chanock, S. J. (2002). A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J. Infect. Dis. 186, 1207–1211.
Copenhaver, C. C., Gern, J. E., Li, Z., Shult, P. A., Rosenthal, L. A., Mikus, L. D., Kirk, C. J., Roberg, K. A., Anderson, E. L., Tisler, C. J., DaSilva, D. F., Hiemke, H. J., Gentile, K., Gangnon, R. E., and Lemanske, R. F., Jr. (2004). Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir. Crit Care Med. 170, 175–180.
de Graaff, P. M., de Jong, E. C., van Capel, T. M., van Dijk, M. E., Roholl, P. J., Boes, J., Luytjes, W., Kimpen, J. L., and van Bleek, G. M. (2005). Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 175, 5904–5911.
Ermers, M. J., Hoebee, B., Hodemaekers, H. M., Kimman, T. G., Kimpen, J. L., and Bont, L. (2007). IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 119(5), 1086–1091.
Feltes, T. F., Cabalka, A. K., Meissner, H. C., Piazza, F. M., Carlin, D. A., Top, F. H., Jr., Connor, E. M., and Sondheimer, H. M. (2003). Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J. Pediatr. 143, 532–540.
Garofalo, R. P., Mei, F., Espejeo, R., Ye, G., Haeberle, H., Baron, S., Ogra, P. L., and Reyes, V. E. (1996). Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class 1 MHC Expression through the induction of IFN-beta and IL-1-alpha. J. Immunol. 157, 2506–2513.
Gern, J. E., Brooks, G. D., Meyer, P., Chang, A., Shen, K., Evans, M. D., Tisler, C., Dasilva, D., Roberg, K. A., Mikus, L. D., Rosenthal, L. A., Kirk, C. J., Shult, P. A., Bhattacharya, A., Li, Z., Gangnon, R., and Lemanske, R. F., Jr. (2006). Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin. Immunol. 117, 72–78.
Goetghebuer, T., Isles, K., Moore, C., Thomson, A., Kwiatkowski, D., and Hull, J. (2004). Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin. Exp. Allergy 34, 801–803.
Graham, B. S., Bunton, L. A., Wright, P. F., and Karzon, D. T. (1991). Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88, 1026–1033.
Graham, B. S., Johnson, T. R., and Peebles, R. S. (2000). Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48, 237–247.
Graham, B. S., Perkins, M. D., Wright, P. F., and Karzon, D. T. (1988). Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26, 153–162.
Haland, G., Carlsen, K. C., Sandvik, L., Devulapalli, C. S., Munthe-Kaas, M. C., Pettersen, M., and Carlsen, K. H. (2006). Reduced lung function at birth and the risk of asthma at 10 years of age. N. Engl. J. Med. 355, 1682–1689.
Hoebee, B., Rietveld, E., Bont, L., Oosten, M., Hodemaekers, H. M., Nagelkerke, N. J., Neijens, H. J., Kimpen, J. L., and Kimman, T. G. (2003). Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J. Infect. Dis. 187, 2–11.
Hull, J., Thomson, A., and Kwiatkowski, D. (2000). Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55, 1023–1027.
Inoue, Y., Shimojo, N., Suzuki, Y., Campos Alberto, E. J., Yamaide, A., Suzuki, S., Arima, T., Matsuura, T., Tomiita, M., Aoyagi, M., Hoshioka, A., Honda, A., Hata, A., and Kohno, Y. (2007). CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population. J. Infect. Dis. 195, 1618–1624.
Janssen, R., Bont, L., Siezen, C. L., Hodemaekers, H. M., Ermers, M. J., Doornbos, G., van't, S. R., Wijmenga, C., Goeman, J. J., Kimpen, J. L., van Houwelingen, H. C., Kimman, T. G., and Hoebee, B. (2007). Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J. Infect. Dis. 196, 826–834.
Johnson, J. E., Gonzales, R. A., Olson, S. J., Wright, P. F., and Graham, B. S. (2007). The histopathology of fatal untreated human respiratory syncytial virus infection. Mod. Pathol. 20, 108–119.
Koenig, J. M., Stegner, J. J., Schmeck, A. C., Saxonhouse, M. A., and Kenigsberg, L. E. (2005). Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness. Pediatr. Res. 57, 424–429.
Levy, O. (2005). Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J. Endotoxin. Res. 11, 113–116.
Levy, O. (2007). Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379–390.
Levy, O., Coughlin, M., Cronstein, B. N., Roy, R. M., Desai, A., and Wessels, M. R. (2006). The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177, 1956–1966.
Levy, O., Zarember, K. A., Roy, R. M., Cywes, C., Godowski, P. J., and Wessels, M. R. (2004). Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173, 4627–4634.
Martinez, F. D., Morgan, W. J., Wright, A. L., Holberg, C. J., and Taussig, L. M. (1988). Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N. Engl. J. Med. 319, 1112–1117.
Molloy, E. J., O'Neill, A. J., Grantham, J. J., Sheridan-Pereira, M., Fitzpatrick, J. M., Webb, D. W., and Watson, R. W. (2005). Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr. Res. 57, 806–812.
Openshaw, P. J. M. (1995). Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol. 17, 187–201.
Peebles, R. S., Jr. and Graham, B. S. (2005). Pathogenesis of respiratory syncytial virus infection in the murine model. Proc. Am. Thorac. Soc. 2, 110–115.
Puthothu, B., Forster, J., Heinzmann, A., and Krueger, M. (2006a). TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis. Markers 22, 303–308.
Puthothu, B., Krueger, M., Forster, J., and Heinzmann, A. (2006b). Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J. Infect. Dis. 193, 438–441.
Renzi, P. M., Turgeon, J. P., Marcotte, J. E., Drblik, S. P., Berube, D., Gagnon, M. F., and Spier, S. (1999). Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am. J. Respir. Crit Care Med. 159, 1417–1422.
Rudd, B. D., Smit, J. J., Flavell, R. A., Alexopoulou, L., Schaller, M. A., Gruber, A., Berlin, A. A., and Lukacs, N. W. (2006). Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J. Immunol. 176, 1937–1942.
Schlender, J., Bossert, B., Buchholz, U., and Conzelmann, K. K. (2000). Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74, 8234–8242.
Schlender, J., Hornung, V., Finke, S., Gunthner-Biller, M., Marozin, S., Brzozka, K., Moghim, S., Endres, S., Hartmann, G., and Conzelmann, K. K. (2005). Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79, 5507–5515.
Simoes, E. A. F. (1999). Respiratory syncytial virus infection. Lancet 354, 847–852.
Smyth, R. L. and Openshaw, P. J. (2006). Bronchiolitis. Lancet 368, 312–322.
Stein, R. T., Sherill, D., Morgan, W. J., Holberg, C. J., Halonen, M., Taussig, L. M., Wright, A. L., and Martinez, F. D. (1999). Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13. Lancet 354, 541–545.
Tal, G., Mandelberg, A., Dalal, I., Cesar, K., Somekh, E., Tal, A., Oron, A., Itskovich, S., Ballin, A., Houri, S., Beigelman, A., Lider, O., Rechavi, G., and Amariglio, N. (2004). Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 189, 2057–2063.
The IMpact-RSV study group (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531–537.
van Woensel, J. and Kimpen, J. (2000). Therapy for respiratory tract infections caused by respiratory syncytial virus. Eur. J. Pediatr. 159, 391–398.
Wang, H., Peters, N., and Schwarze, J. (2006). Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol. 177, 6263–6270.
Yusuf, S., Piedimonte, G., Auais, A., Demmler, G., Krishnan, S., VAN, C. P., Singleton, R., Broor, S., Parveen, S., Avendano, L., Parra, J., Chavez-Bueno, S., DE Sierra, T. M., Simoes, E. A., Shaha, S., and Welliver, R. (2007). The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol. Infect. 135, 1077–1090.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bont, L. (2009). Current Concepts of the Pathogenesis of RSV Bronchiolitis. In: Finn, A., Curtis, N., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children V. Advances in Experimental Medicine and Biology, vol 634. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79838-7_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-79838-7_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79837-0
Online ISBN: 978-0-387-79838-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)